Liver Disease News & Hepatitis News from Medical News Today

Liver Disease / Hepatitis News

Liver Disease / Hepatitis News

The latest Liver Disease News & Hepatitis News articles published daily. Includes news on Inflammation of the liver, cirrhosis, cysts, hepatitis A, B and C and much more.

Add this Liver Disease rss news feed to your rss reader:

Latest News

Liver Disease - Can-Fite Successfully Completed Phase I Clinical Trial With Its 2nd Drug CF102

07 May 2008

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced the successful completion of a phase I clinical trial with its second pipeline drug, CF102...
[read article]

EPA Registered Disinfectant Kills Both Known Types Of MRSA

06 May 2008

While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers...
[read article]

Health Department Encourages Public To Learn Risk Factors For Viral Hepatitis

05 May 2008

The Alabama Department of Public Health and the Centers for Disease Control and Prevention urge the public to learn the risk factors of viral hepatitis during May, Hepatitis Awareness Month...
[read article]

Liver Disease / Hepatitis News Articles Archive - Page 1

03 May 2008

New Findings: The Anti-Fibrotic Mechanism Of Plant Extract Cpd 861

02 May 2008

P-HOP Event To Provide Free Hepatitis C Testing To The Community - P-HOP Recognizes May As Hepatitis Awareness Month

01 May 2008

Managing Chinese Obese Children With Non-Alcoholic Fatty Liver Disease

Anti-HAV Antibodies In Beta-Thalassemia

High Circulating D-Dimers Are Associated With Presence Of Ascites

Anti-HBe May Play A Role In The Progression Of The Disease Of Hepatitis B

29 April 2008

Clinical Update - Debio 025 In Hepatitis C

28 April 2008

European Commission Approves Viread For Chronic Hepatitis B

27 April 2008

Team Develops Safe, Effective RNA Interference Technique - Method Holds Promise For Treating Cancer And Infection

Roche's Investigational Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Response In Phase IIa Study

Final Results Of Ideal Study Presented At Annual Meeting Of The European Association For The Study Of The Liver (EASL)

Three Studies Presented At 43rd EASL Showed Higher SVR For PEGASYS(R) (Peginterferon Alfa-2a) Plus Ribavirin Than Peginterferon Alfa-2b Plus Ribavirin

BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared To Adefovir At 96 Weeks In Hepatitis B Positive Patients

Interim Results From Boceprevir Phase II Study In Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL

26 April 2008

Important Progress Toward Control Of Hepatitis B And C

25 April 2008

Biolex Therapeutics Researchers Present Locteron(R) Phase 2a Hepatitis C Trial Results At EASL Conference

Gilead Announces 72-Week Data From Two Pivotal Phase III StudiesEvaluating Viread(R) For The Treatment Of Chronic Hepatitis B

Data On Investigational Compounds Being Co-Developed By Tibotec For The Treatment Of Chronic Hepatitis C Presented At EASL 2008

Positive Findings In Treating Patients With Advanced Hepatitis C

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb Data Presentation At European Association For The Study Of Liver (EASL) Annual Meeting

Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) For The Treatment Of Chronic Hepatitis B

Antipodean Pharmaceuticals Announces Results Of Phase 2 Study Of Lead Compound MitoQ(R)

NAFLD AND NASH Linked To Metabolic Syndrome And Cardiovascular Disease

Pharmasset Adds Two Cohorts To R7128 Hepatitis C Study

24 April 2008

Positive Preclinical Data On HCV Programs At The Annual Meeting Of The European Association For The Study Of The Liver (EASL), Idenix Pharmaceuticals

Idenix Pharmaceuticals Presents Positive Preclinical Data On HCV Programs At The Annual Meeting Of The European Association For The Liver

Romark Announces Presentation Of New Data For Nitazoxanide In Chronic Hepatitis C At EASL 2008

23 April 2008

In The Battle Against Hospital Infections 'Crime Scene Investigation' Methods Could Help

21 April 2008

Technology To Detect Liver Disease Via Blood Test To Be Developed

19 April 2008

Romark Laboratories Initiates Phase II Study Of Nitazoxanide In Treatment-Naive Patients With Chronic Hepatitis C Genotype 1

18 April 2008

Schering-Plough Highlights PEGINTRON(TM) And Boceprevir Data Presentations At European Association For The Study Of The Liver (EASL) Annual Meeting

17 April 2008

A Phase II Study Of The Efficacy And Tolerability Of Lapatinib In Patients With Advanced Hepatocellular Carcinomas

16 April 2008

Survival Rates Doubled By Combining Liver Cancer Treatments, UVA Researchers Find

Delayed Umbilical Cord Clamping: Health Risks And Benefits

14 April 2008

New Technique In Treating Patients With Liver Cancer Proves Effective

Researchers Find That Targeted Therapy Combination Overcomes Treatment Resistance In Liver Cancer

11 April 2008

Antipodean Pharmaceuticals Announces Completion Of Phase 2 Study Of Lead Compound MitoQ(R)

Researchers Identify Treatment Target For Liver Cancer Recurrence And Survival

09 April 2008

Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection

Roche Diagnostics Expands Availability Of Hepatitis C Virus (HCV) Immunoassay

08 April 2008

For Patients With Advanced Liver Cancer, Hope Found In Combination Therapy

03 April 2008

Early-Onset Obesity In Father Linked To Increased Potential For Liver Disease In Child

Delcath Systems Presents Positive Phase II Data On Delcath PHP System In Treatment Of Inoperable Liver Metastases

28 March 2008

Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted In Higher SVR Than Flat Dosing; Low Relapse Rates In Patients With Chronic Hepatitis C

27 March 2008

Lifetime Effects Of Pediatric Liver Transplants

25 March 2008

BARACLUDE Data Show Low Resistance Over 5 Years In Nucleoside-Naive Hepatitis B Patients

Baraclude(R) Data Continue To Demonstrate Low Incidence Of Resistance Through 5 Years Of Treatment IN NUCLeoside-naive Chronic Hepatitis B Patients

Dramatic Rise In Hepatitis C-Related Deaths In The United States With Greatest Risk To Middle-Aged Patients

Discovery Of Certain Liver Disease Related To Cardiovascular Fitness

BARACLUDE(R) Data Continue To Demonstrate Low Incidence Of Resistance Through Five Years Of Treatment In Nucleoside-naive Chronic Hepatitis B Patients

24 March 2008

Process Discovered To Disrupt Hepatitis C Virion Production

22 March 2008

Hepatitis B Foundation Testifies Before Congressional Appropriation Committee And Urges More Federal Funding For Hepatitis B

21 March 2008

European CHMP Issues Positive Opinion For Viread® For The Treatment Of Chronic Hepatitis B

19 March 2008

What Change Does Prokineticin 2/Bv8 Have In Human Hepatocellular Carcinoma?

Living Donor Liver Transplants Improved Outcome Using New Technique

18 March 2008

Possible New Treatment Strategy For Muscular Dystrophy

14 March 2008

J&J Subsidiary, FDA Warn Against Death, Liver Damage Risk For People Taking Antiretroviral Prezista

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]